| Fri, 23 Aug 2019 11:52:16: | Scorpion toxin uncovers insights into pain that could inspire non-opioid treatments
|
| Fri, 23 Aug 2019 10:52:52: | GSK's anti-BCMA drug hits goal in pivotal multiple myeloma test
|
| Fri, 23 Aug 2019 01:34:00: | Chutes & Ladders—Garraway will take over as Roche's next CMO
|
| Thu, 22 Aug 2019 13:29:57: | AstraZeneca pays Sobi $95M for priority review voucher
|
| Thu, 22 Aug 2019 12:41:07: | As Brexit nears, Britain's drugs, devices and pricing regulators seek the exit
|
| Thu, 22 Aug 2019 12:29:51: | Finch raises $53M to push microbiome drug to key readout
|
| Thu, 22 Aug 2019 11:40:52: | Roche's effort to stop cancer metastasis unexpectedly leads to a Merck drug
|
| Thu, 22 Aug 2019 07:25:28: | U.S. cancer trials still suffering from lack of diversity: report
|
| Wed, 21 Aug 2019 13:03:49: | Merck teams up with Themis to develop vaccines
|
| Wed, 21 Aug 2019 12:36:22: | Chasing Astellas and Mitsubishi, GSK files for Japanese approval of oral anemia drug
|
| Wed, 21 Aug 2019 10:27:55: | Building a human brain 'parts list' for better treatments
|
| Wed, 21 Aug 2019 06:19:20: | Oncorus raises $80M for 2-front oncolytic virus R&D push
|
| Tue, 20 Aug 2019 12:07:18: | Pfizer's charity backs infectious disease projects
|
| Tue, 20 Aug 2019 10:41:57: | Synlogic scraps ammonia-lowering drug after early phase fail
|
| Mon, 19 Aug 2019 14:56:44: | Lilly's Garraway on his way to Roche as veteran Horning set to exit by year-end
|
| Mon, 19 Aug 2019 12:49:19: | Restoring neurons to preserve memory after heart attack or stroke
|
| Mon, 19 Aug 2019 12:21:32: | SpringWorks plans $115M IPO to take ex-Pfizer drugs to market
|
| Mon, 19 Aug 2019 08:59:42: | Juvenescence raises $100M to fund longevity assets to early readouts
|
| Fri, 16 Aug 2019 12:41:16: | Monopar files for $40M IPO to test chemo side effect drug
|
| Fri, 16 Aug 2019 12:05:12: | Alector, Prevail trade blows over alleged misuse of confidential information
|
| Thu, 15 Aug 2019 21:03:25: | Chutes & Ladders—GlaxoSmithKline poaches Merck KGaA exec to run U.S. pharma
|
| Thu, 15 Aug 2019 15:16:47: | How nematode worms could inspire safer opioid use
|
| Thu, 15 Aug 2019 12:55:52: | Ultragenyx snags option on antisense startup GeneTx
|
| Thu, 15 Aug 2019 12:25:16: | Y-mAbs ramps up head count in post-IPO hiring spree
|
| Thu, 15 Aug 2019 11:48:10: | AstraZeneca drug heads to phase 2 in pancreatic cancer after small trial extends survival
|
